Literature DB >> 11420306

Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress.

S Uemura1, H Matsushita, W Li, A J Glassford, T Asagami, K H Lee, D G Harrison, P S Tsao.   

Abstract

Diabetes mellitus (DM) is a primary risk factor for cardiovascular disease. Although recent studies have demonstrated an important role for extracellular matrix metalloproteinases (MMPs) in atherosclerosis, little is known about the effects of hyperglycemia on MMP regulation in vascular cells. Gelatin zymography and Western blot analysis revealed that the activity and expression of 92-kDa (MMP-9) gelatinase, but not of 72 kDa (MMP-2) gelatinase, were significantly increased in vascular tissue and plasma of two distinct rodent models of DM. Bovine aortic endothelial cells (BAECs) grown in culture did not express MMP-9 constitutively; however, chronic (2-week) incubation with high glucose medium induced MMP-9 promoter activity, mRNA and protein expression, and gelatinase activity in BAECs. On the other hand, high glucose culture did not change MMP-9 activity from vascular smooth muscle cells or macrophages. Electron paramagnetic resonance studies indicate that BAECs chronically grown in high glucose conditions produce 70% more ROS than do control cells. Enhanced MMP-9 activity was significantly reduced by treatment with the antioxidants polyethylene glycol-superoxide dismutase and N-acetyl-L-cysteine but not by inhibitors of protein kinase C. In conclusion, vascular MMP-9 activity is increased in DM, in part because of enhanced elaboration from vascular endothelial cells, and oxidative stress plays an important role. This novel mechanism of redox-sensitive MMP-9 expression by hyperglycemia may provide a rationale for antioxidant therapy to modulate diabetic vascular complications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420306     DOI: 10.1161/hh1201.092042

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  114 in total

1.  Diabetic peripheral neuropathy: an update on pathogenesis and management.

Authors:  Betul M Gundogdu
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

2.  Emodin-6-O-β-D--glucoside inhibits high-glucose-induced vascular inflammation.

Authors:  Wonhwa Lee; Sae-Kwang Ku; Doohyun Lee; Taeho Lee; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

3.  Orientin inhibits high glucose-induced vascular inflammation in vitro and in vivo.

Authors:  Sae-Kwang Ku; Soyoung Kwak; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

4.  High glucose induced rat aorta vascular smooth muscle cell oxidative injury: involvement of protein tyrosine nitration.

Authors:  Yuling Zhao; Naihao Lu; Yan Zhang; Zhonghong Gao
Journal:  J Physiol Biochem       Date:  2011-05-28       Impact factor: 4.158

5.  GLP-1 reduces metalloproteinase-14 and soluble endoglin induced by both hyperglycemia and hypoglycemia in type 1 diabetes.

Authors:  Antonio Ceriello; Lucia La Sala; Valeria De Nigris; Gemma Pujadas; Roberto Testa; Annachiara Uccellatore; Stefano Genovese
Journal:  Endocrine       Date:  2015-03-06       Impact factor: 3.633

6.  Rice bran protein hydrolysates reduce arterial stiffening, vascular remodeling and oxidative stress in rats fed a high-carbohydrate and high-fat diet.

Authors:  Ketmanee Senaphan; Weerapon Sangartit; Poungrat Pakdeechote; Veerapol Kukongviriyapan; Patchareewan Pannangpetch; Supawan Thawornchinsombut; Stephen E Greenwald; Upa Kukongviriyapan
Journal:  Eur J Nutr       Date:  2016-09-22       Impact factor: 5.614

Review 7.  Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.

Authors:  Yinan Hua; Sreejayan Nair
Journal:  Biochim Biophys Acta       Date:  2014-05-09

8.  Selenium restores defective beta-adrenergic receptor response of thoracic aorta in diabetic rats.

Authors:  Esma N Zeydanli; Ayca Bilginoglu; Evrim Tanriverdi; Hakan Gurdal; Belma Turan
Journal:  Mol Cell Biochem       Date:  2009-12-18       Impact factor: 3.396

9.  Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy.

Authors:  Rui Ni; Ting Cao; Sidong Xiong; Jian Ma; Guo-Chang Fan; James C Lacefield; Yanrong Lu; Sydney Le Tissier; Tianqing Peng
Journal:  Free Radic Biol Med       Date:  2015-11-11       Impact factor: 7.376

10.  TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1.

Authors:  Marina Cardellini; Rossella Menghini; Eugenio Martelli; Viviana Casagrande; Arianna Marino; Stefano Rizza; Ottavia Porzio; Alessandro Mauriello; Anna Solini; Arnaldo Ippoliti; Renato Lauro; Franco Folli; Massimo Federici
Journal:  Diabetes       Date:  2009-07-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.